Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-25-041470

Options or other derivatives

  • Chief Medical Officer acquired 79,167 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Naimish Chief Medical Officer 2025-03-14 Grant or award · Stock Option (Right to Buy) +46,667 46,667 D
Patel Naimish Chief Medical Officer 2025-03-14 Grant or award · Restricted Stock Units +32,500 32,500 D
Loading xslF345X05/ownership.xml…